[Pain management in osteoporosis]
L Heuchemer1, D Emmert1, T Bender1
1Zentrum für Seltene Erkrankungen (ZSEB), Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland.
Der Orthopade
|March 21, 2020
Summary
Osteoporosis, a common global disease, causes reduced bone density, increasing fracture risk and pain. Effective pain management, including pharmacological and non-pharmacological options, is crucial for improving patient quality of life.
Area of Science:
- Orthopedics and Musculoskeletal Disorders
- Pain Management
- Geriatric Medicine
Background:
- Osteoporosis is a widespread condition characterized by decreased bone density, leading to heightened fracture susceptibility and reduced stature.
- Pain, both acute and chronic, is a significant complication of osteoporosis, frequently manifesting in the back and severely impacting quality of life.
- Optimal patient care necessitates a thorough understanding of pain management strategies specific to osteoporosis.
Purpose of the Study:
- To provide a comprehensive review of pain management in osteoporosis.
- To elucidate the underlying pathomechanisms contributing to pain in osteoporosis.
- To outline risk factors and diagnostic procedures for osteoporosis-related pain.
Main Methods:
- Literature review of pharmacological treatments for osteoporosis pain.
- Analysis of non-pharmacological interventions for osteoporosis pain.
- Review of pathomechanisms, risk factors, and diagnostic methods for osteoporosis.
Main Results:
- Identified key pharmacological agents and non-pharmacological approaches for managing osteoporosis-associated pain.
- Detailed the complex pathomechanisms underlying pain in osteoporosis.
- Summarized established risk factors and current diagnostic procedures for the condition.
Conclusions:
- Effective pain management in osteoporosis requires a multifaceted approach, integrating pharmacological and non-pharmacological strategies.
- Understanding the etiology and risk factors is vital for accurate diagnosis and tailored treatment plans.
- This review offers a comprehensive resource for clinicians managing pain in patients with osteoporosis.
Keywords:
Absorptiometry, dual-energy x‑rayAnalgesics, opioidBisphosphonatesFracture riskPhysical therapy modalitiesMore Related Videos
Related Concept Videos
Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Peripheral Artery Disease V: Postoperative Nursing Management
265
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
265
Bone Remodeling
40.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.1K
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Peptic Ulcer Disease IV: Management
358
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
358
Osteoclasts in Bone Remodeling
3.7K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.7K


